000 | 01831 a2200469 4500 | ||
---|---|---|---|
005 | 20250515134435.0 | ||
264 | 0 | _c20090513 | |
008 | 200905s 0 0 eng d | ||
022 | _a1357-0560 | ||
024 | 7 |
_a10.1007/s12032-008-9064-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLin, Cheng-Jui | |
245 | 0 | 0 |
_aAcute tumor lysis syndrome in a hemodialysis patient with diffuse large B cell lymphoma. _h[electronic resource] |
260 |
_bMedical oncology (Northwood, London, England) _c2009 |
||
300 |
_a93-5 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 |
_aAllopurinol _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
650 | 0 | 4 | _aBlood Cell Count |
650 | 0 | 4 | _aBlood Chemical Analysis |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
650 | 0 | 4 |
_aLymphoma, Large B-Cell, Diffuse _xblood |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRenal Dialysis |
650 | 0 | 4 |
_aTumor Lysis Syndrome _xetiology |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
700 | 1 | _aChen, Han-Hsiang | |
700 | 1 | _aHsieh, Ruey-Kuen | |
700 | 1 | _aChen, Yi-Chou | |
700 | 1 | _aWu, Chih-Jen | |
773 | 0 |
_tMedical oncology (Northwood, London, England) _gvol. 26 _gno. 1 _gp. 93-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12032-008-9064-0 _zAvailable from publisher's website |
999 |
_c18239947 _d18239947 |